Why this matters: Three distinct ORTEX data streams—utilisation, short interest, and options sentiment—have converged on HLN within the past week, signalling rising pressure on the stock's borrowing market.
Utilisation hit 90.9% on April 22, the highest reading in recent months and approaching the 52-week peak of 100%. Utilisation measures how much of the available share supply has been lent out. The current 87.3% reading remains elevated. HLN ranks in the 82nd percentile for utilisation among its peers.
Short interest climbed 37% over the past month to 23.07 million shares. The one-week increase alone was 8.3%. Official FINRA data for the April 15 settlement showed 12.36 million shares short, with days to cover at 1.88.
Put-call ratio jumped to 0.111 on April 24, up from a 20-day average of 0.087. The PCR now sits 3.2 standard deviations above its recent mean, the highest since the 52-week peak of 0.22. The reading suggests defensive positioning has increased sharply.
Insider activity shows net selling. Lisa Paley, a divisional president, sold $1.38 million in March 2025. The data is now 409 days old.
Major institutional holders have added shares in Q1. Massachusetts Financial Services increased its stake by 18.4 million shares. Principal Global Investors added 13.1 million shares. Schroder Investment Management added 35.5 million shares.
See the live data behind this article on ORTEX.
Open HLN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
